{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-031441","form_type":"8-K","ticker":"HCWB","cik":"0001828673","company_name":"HCW Biologics Inc.","filed_at":"2026-07-01T12:30:14+00:00","discovered_at":"2026-07-01T12:35:01.353888+00:00","generated_at":"2026-07-01T12:35:22.194976+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"HCW Biologics settles $2.8M in disputed payables; lien removed, EirGenix obligation cleared","bullets":["Settlement extinguishes $2.8 million in disputed accounts payable, reported in Q2 ending June 30, 2026.","B&I Contractors dismissed crossclaims with prejudice and filed satisfaction of $1.1M mechanics' lien on company property.","Company paid $1.24M to EirGenix under settlement reducing original $1.7M obligation; final payment on May 26, 2026.","Two $620k payments (March 3 and May 26, 2026) fully settled disputed EirGenix manufacturing costs.","All outstanding amounts related to these disputes are fully resolved with no remaining liabilities."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-031441","json":"https://secwatch.observer/filing/0001493152-26-031441.json","markdown":"https://secwatch.observer/filing/0001493152-26-031441.md","text":"https://secwatch.observer/filing/0001493152-26-031441.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1828673/000149315226031441/0001493152-26-031441-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1828673/000149315226031441/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-01T12:35:22.194976+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}